Indogulf Cropsciences hosts Q1 FY27 earnings call on August 18

1 min read     Updated on 13 Aug 2026, 11:53 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Indogulf Cropsciences Limited announced it will host its Q1 FY27 earnings conference call on August 18, 2026, at 11:00 am IST. Managing Director Sanjay Aggarwal and CFO Manoj Gupta will lead the discussion on financial results. The filing complies with SEBI Listing Regulations.

powered bylight_fuzz_icon
48147814

*this image is generated using AI for illustrative purposes only.

Indogulf Cropsciences will host its earnings conference call for the first quarter of fiscal year 2027 on Tuesday, August 18, 2026, at 11:00 am IST. The event aims to provide investors with an update on the company's recent financial performance and strategic direction.

The management team will lead the discussion, offering insights into operational metrics and business developments during the quarter.

Conference Call Details

The conference call is scheduled to begin at 11:00 am IST. Participants can join via dial-in numbers or through a pre-registration link to avoid waiting queues.

Detail Information
Date August 18, 2026
Time 11:00 am IST
Universal Access +91 22 6280 1102
International Toll Free (USA) 1 866 746 2133

Management Representatives

The following executives will participate in the call:

  • Sanjay Aggarwal, Managing Director
  • Manoj Gupta, Chief Financial Officer

Regulatory Disclosure

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company filed the notice with both the Bombay Stock Exchange and the National Stock Exchange of India Limited.

For further information, investors may contact Adfactors PR, the investor relations agency handling communications for Indogulf Cropsciences.

Historical Stock Returns for Indogulf Cropsciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.16%-5.68%-6.13%+0.08%-33.08%-35.84%

How might Indogulf Cropsciences' Q1 FY27 results influence its valuation relative to other agrochemical peers in the Indian market?

What specific strategic initiatives or R&D breakthroughs is management expected to highlight regarding their long-term growth trajectory?

Could changes in global raw material prices or regulatory policies impact the company's operational margins in the upcoming quarters?

like18
dislike

Indogulf Cropsciences Q1 Results: Net Profit Down 38% YoY; EBITDA Margin Rises to 5.7%

2 min read     Updated on 12 Aug 2026, 12:08 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Indogulf Cropsciences reported a Q1 consolidated net profit of ₹24.14 million, down 37.6% YoY from ₹38.67 million, as consolidated revenue fell 11% to ₹1,685.45 million. EBITDA stood at ₹96 million versus ₹99 million in the year-ago period, while EBITDA margin improved slightly to 5.7% from 5.24%. Rising raw material costs and higher finance charges weighed on profitability despite marginal improvement in operating efficiency.

powered bylight_fuzz_icon
48062167

*this image is generated using AI for illustrative purposes only.

Indogulf Cropsciences Limited reported a consolidated net profit of ₹24.14 million for the quarter ended June 30, 2026, marking a 37.6% decline from the ₹38.67 million profit recorded in Q1FY25. Despite the drop in profitability, the company's EBITDA came in at ₹96 million versus ₹99 million in the year-ago period, while EBITDA margin improved slightly to 5.7% from 5.24% year-on-year. The contraction in earnings reflects broader margin pressures within the agro-chemical sector, where rising input costs have outpaced revenue generation.

The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on August 12, 2026, at the company's registered office in New Delhi. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Devesh Parekh & Co., in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors issued an unmodified opinion on the financial statements.

Consolidated revenue from operations stood at ₹1,685.45 million for Q1FY26, down 11% year-on-year from ₹1,893.72 million. Standalone revenue also contracted by 12.3% to ₹1,623.96 million, compared to ₹1,851.38 million in the corresponding quarter of the previous fiscal year. Other income decreased marginally to ₹8.85 million on a consolidated basis, while standalone other income rose slightly to ₹14.00 million.

Financial Performance Breakdown

The following table summarises the key financial metrics across consolidated and standalone bases for Q1FY26 and Q1FY25:

Metric Consolidated Q1FY26 Consolidated Q1FY25 Standalone Q1FY26 Standalone Q1FY25
Revenue from Operations (₹ Million) 1,685.45 1,893.72 1,623.96 1,851.38
Total Income (₹ Million) 1,694.30 1,903.05 1,637.96 1,861.69
Total Expenses (₹ Million) 1,662.75 1,856.67 1,608.88 1,825.69
EBITDA (₹ Million) 96.00 99.00 — —
EBITDA Margin (%) 5.70 5.24 — —
Profit Before Tax (₹ Million) 31.24 46.49 28.77 36.11
Net Profit (₹ Million) 24.14 38.67 22.69 29.54
EPS Basic (₹) 0.38 0.80 0.36 0.61

The company's total consolidated expenses amounted to ₹1,662.75 million, with the cost of raw material and components consumed being the largest component at ₹1,465.84 million. Employee benefits expense rose to ₹137.13 million from ₹126.71 million in the year-ago period. Finance costs increased to ₹45.10 million from ₹37.85 million. Standalone expenses followed a similar pattern, totaling ₹1,608.88 million.

What the Numbers Show

A key observation from the Q1FY26 results is the divergence between revenue decline and expense behaviour. While consolidated revenue fell by approximately 11%, the absolute value of total expenses decreased by only 10.4%. The structure of expenses reveals pressure points: the cost of raw materials remained high relative to output, compressing margins. The profit before tax dropped sharply from ₹46.49 million to ₹31.24 million, indicating that fixed costs and financing charges did not decrease proportionally with the dip in sales. Notably, EBITDA margin expanded to 5.7% from 5.24% year-on-year, suggesting some improvement in operating efficiency even as absolute EBITDA slipped from ₹99 million to ₹96 million. Additionally, exceptional items recorded a loss of ₹0.31 million due to the disposal of fixed assets, further impacting the bottom line. The foreign subsidiary, Indogulf Cropsciences Australia Pty Ltd., contributed unaudited financial information which management deemed not material to the group's overall results.

Historical Stock Returns for Indogulf Cropsciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.16%-5.68%-6.13%+0.08%-33.08%-35.84%

What specific strategies is Indogulf Cropsciences planning to implement to offset rising raw material costs and restore revenue growth in Q2FY26?

How will the increasing finance costs, which rose to ₹45.10 million, impact the company's debt servicing capacity and future capital allocation decisions?

Given the 11% revenue decline, does management anticipate a seasonal recovery in agro-chemical demand later in FY26, or is this indicative of a structural market downturn?

like16
dislike

More News on Indogulf Cropsciences

1 Year Returns:-33.08%